Medtronic stock trades at EUR 76.28 as guidance rises

Published on 09/30/2026 at 15:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic stock trades at EUR 76.28 at Lang & Schwarz on September 30, 2026. Fiscal Q1 revenue reached USD 9.756 billion, up 13.7 percent year over year.

Reinraumfertigung mit Technikern bei Montage medizintechnischer Präzisionsinstrumente — Medtronic plc (ISIN IE00BTN1Y115) Reinraum-Fertigung zeigt Techniker bei der Montage medizinischer Präzisionsinstrumente sorgfältig, Illustration mit AI erstellt.

Medtronic (ISIN IE00BTN1Y115) was trading at EUR 76.28 at Lang & Schwarz on September 30, 2026 at 3:34 p.m. CEST, down 0.50 percent versus the prior close of EUR 76.66. The latest operating signal came from fiscal first-quarter results, which showed double-digit revenue growth and prompted higher full-year guidance.

Revenue growth reaches 13.7 percent

According to Medtronic on September 1, 2026, revenue for Q1 FY27, ended July 31, 2026, reached USD 9.756 billion. That was 13.7 percent above the USD 8.578 billion reported for the comparable fiscal quarter.

GAAP diluted EPS increased to USD 1.14 from USD 0.81, a 40.74 percent gain. Non-GAAP diluted EPS was USD 1.45, while GAAP operating profit rose to USD 1.764 billion and the GAAP operating margin reached 18.1 percent.

Guidance moves to 7.25 percent

Medtronic raised its fiscal 2027 organic revenue growth guidance to 7.25 percent to 7.75 percent from 6.75 percent to 7.25 percent. The company also lifted its diluted non-GAAP EPS guidance to USD 5.94 to USD 6.00 from USD 5.90 to USD 6.00, keeping the lower end of the range as the key change.

The quarter was broad-based: Cardiovascular revenue rose 18.9 percent organically to USD 3.906 billion, Neuroscience increased 9.3 percent to USD 2.653 billion, and Medical Surgical grew 10.2 percent to USD 2.265 billion. Diabetes revenue increased 14.9 percent organically to USD 829 million, according to the September 1 release.

Analyst expectations also remain above the latest euro quote. MarketBeat reported on September 30, 2026 that TD Cowen reiterated a Buy rating and a USD 110.00 price target. Wells Fargo had raised its target from USD 102.00 to USD 104.00 on September 2, 2026, while the reported consensus target was USD 103.92.

Stock trades at EUR 76.28

The Lang & Schwarz quote puts Medtronic stock below its recent primary-market reference range. The NYSE quotation was listed in USD, with a 52-week range of USD 73.31 to USD 106.33 and market capitalization of USD 111.0 billion as of September 30, 2026. The next market question is whether the raised growth outlook can translate into sustained execution after the unusually strong first quarter.